This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by E. Naserke, H. Articles by Ziegler, A.-G. Search for Related Content PubMed PubMed Citation Articles by E. Naserke, H. Articles by Ziegler, A.-G.

Prevalence, Characteristics and Diabetes Risk Associated with Transient Maternally Acquired Islet Antibodies and Persistent Islet Antibodies in Offspring of Parents with Type 1 Diabetes

Institute of Diabetes Research (H.E.N.) and Institute of Diabetes Research and Academic Hospital Schwabing (A.-G.Z.), D-80804 Munich, Germany; and Istituto Scientifico San Raffaele (E.B.), I-20732 Milan, Italy

Address all correspondence and requests for reprints to: Prof. Dr. Anette-G. Ziegler, Institut für Diabetesforschung, Kölner Platz 1, D-80804 Munich, Germany. E-mail: anziegler{at}lrz.uni-muenchen.de

Abstract

Accurate assessment of type 1 diabetes risk in young children requires discrimination between antibodies that are produced by the child and antibodies acquired through the placenta from an islet antibody-positive mother. We studied 682 offspring from mothers with type 1 diabetes and 329 offspring from fathers with type 1 diabetes and nondiabetic mothers for insulin (auto)antibodies, glutamic acid decarboxylase antibodies, and tyrosine phosphatase IA-2 antibodies before age 1 yr and again at age 2 yr to ascertain transience or persistence. Antibodies were detected at age 9 months in 5 (1.5%) offspring from fathers with type 1 diabetes; all were insulin (auto)antibodies only, all persisted and developed multiple antibodies, and 1 developed type 1 diabetes. In contrast, 31 (4.5%) offspring from mothers with type 1 diabetes had antibodies at 9 months; 12 (1.8%) persisted at age 2 yr, and 19 (2.8%) did not persist, suggestive of transient residual maternal antibodies. Multiple antibodies at 9 months were usually persistent (3 of 4 offspring), as were single insulin (auto)antibodies in offspring from mothers with type 1 diabetes (8 of 13 offspring), whereas persistent glutamic acid decarboxylase antibodies (1 of 12) and tyrosine phosphatase IA-2 antibodies (0 of 2) were rare. Offspring with persistent antibodies at age 9 months had a high type 1 diabetes risk (100% by age 5 yr for those with multiple antibodies and 27% for single antibodies at 9 months), whereas offspring with transient antibodies had 0% type 1 diabetes risk (P < 0.01). Transience was associated with very high antibody levels at birth. For insulin (auto)antibodies, the measurement of subclass was also informative. Residual maternal antibody was indicated by similar insulin (auto)antibodies subclasses at 9 months and at birth, whereas different subclasses were indicative of nonmaternal antibody. Moreover, the presence of IgG1-insulin (auto)antibodies was associated with antibody persistence and type 1 diabetes risk. These strategies are helpful in discriminating high and low risk antibodies before age 1 yr and should be important for prognosis and reducing unnecessary parent anxiety.

This article has been cited by other articles:

				P. Achenbach, E. Bonifacio, K. Koczwara, and A.-G. Ziegler Natural History of Type 1 Diabetes Diabetes, December 1, 2005; 54(suppl_2): S25 - S31. [Abstract] [Full Text] [PDF]

				E. Melanitou, D. Devendra, E. Liu, D. Miao, and G. S. Eisenbarth Early and Quantal (by Litter) Expression of Insulin Autoantibodies in the Nonobese Diabetic Mice Predict Early Diabetes Onset J. Immunol., December 1, 2004; 173(11): 6603 - 6610. [Abstract] [Full Text] [PDF]

				R. Nemni, L. M. Caniatti, M. Gironi, E. Bazzigaluppi, and D. De Grandis Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodies Neurology, June 8, 2004; 62(11): 2101 - 2102. [Abstract] [Full Text] [PDF]

				P. Achenbach, K. Warncke, J. Reiter, H. E. Naserke, A. J.K. Williams, P. J. Bingley, E. Bonifacio, and A.-G. Ziegler Stratification of Type 1 Diabetes Risk on the Basis of Islet Autoantibody Characteristics Diabetes, February 1, 2004; 53(2): 384 - 392. [Abstract] [Full Text] [PDF]

				K. Koczwara, E. Bonifacio, and A.-G. Ziegler Transmission of Maternal Islet Antibodies and Risk of Autoimmune Diabetes in Offspring of Mothers With Type 1 Diabetes Diabetes, January 1, 2004; 53(1): 1 - 4. [Abstract] [Full Text] [PDF]

				M. Atkinson and E. A. M. Gale Infant Diets and Type 1 Diabetes: Too Early, Too Late, or Just Too Complicated? JAMA, October 1, 2003; 290(13): 1771 - 1772. [Full Text] [PDF]